Apyx Medical (APYX) Competitors $3.21 +0.31 (+10.69%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$3.12 -0.09 (-2.65%) As of 10/24/2025 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APYX vs. KIDS, TMCI, DCTH, CARL, SMLR, NPCE, DRTS, RXST, TCMD, and BWAYShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Carlsmed (CARL), Semler Scientific (SMLR), NeuroPace (NPCE), Alpha Tau Medical (DRTS), RxSight (RXST), Tactile Systems Technology (TCMD), and Brainsway (BWAY). These companies are all part of the "medical equipment" industry. Apyx Medical vs. Its Competitors OrthoPediatrics Treace Medical Concepts Delcath Systems Carlsmed Semler Scientific NeuroPace Alpha Tau Medical RxSight Tactile Systems Technology Brainsway Apyx Medical (NASDAQ:APYX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership. Do institutionals & insiders believe in APYX or KIDS? 55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 15.2% of Apyx Medical shares are owned by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer APYX or KIDS? In the previous week, Apyx Medical had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 5 mentions for Apyx Medical and 4 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.53 beat Apyx Medical's score of 0.50 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, APYX or KIDS? Apyx Medical has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Which has stronger valuation and earnings, APYX or KIDS? Apyx Medical has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$48.10M2.52-$23.46M-$0.45-7.13OrthoPediatrics$204.73M2.09-$37.82M-$1.79-9.51 Do analysts prefer APYX or KIDS? OrthoPediatrics has a consensus price target of $26.29, indicating a potential upside of 54.35%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00OrthoPediatrics 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is APYX or KIDS more profitable? OrthoPediatrics has a net margin of -18.92% compared to Apyx Medical's net margin of -37.11%. OrthoPediatrics' return on equity of -6.36% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-37.11% -158.22% -28.30% OrthoPediatrics -18.92%-6.36%-4.69% SummaryOrthoPediatrics beats Apyx Medical on 10 of the 16 factors compared between the two stocks. Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$121.40M$11.08B$6.21B$10.81BDividend YieldN/A1.88%5.72%4.80%P/E Ratio-7.1321.4531.6030.98Price / Sales2.5231.07595.06133.64Price / CashN/A25.0837.2561.86Price / Book8.453.5012.056.61Net Income-$23.46M$210.63M$3.34B$277.10M7 Day Performance9.93%0.74%1.94%2.57%1 Month Performance58.91%2.73%6.88%3.20%1 Year Performance165.29%-7.76%56.06%33.22% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical1.4931 of 5 stars$3.21+10.7%N/A+165.3%$121.40M$48.10M-7.13270News CoverageAnalyst ForecastKIDSOrthoPediatrics4.558 of 5 stars$17.75+0.8%$26.29+48.1%-33.7%$442.44M$204.73M-9.86200Upcoming EarningsAnalyst ForecastTMCITreace Medical Concepts2.1396 of 5 stars$6.84+0.6%$9.67+41.3%+46.5%$430.13M$209.36M-8.62250News CoveragePositive NewsAnalyst ForecastDCTHDelcath Systems2.7082 of 5 stars$11.49+0.6%$25.00+117.6%-4.2%$399.44M$37.21M228.3860News CoverageAnalyst ForecastAnalyst RevisionCARLCarlsmedN/A$14.12-1.9%N/AN/A$375.32M$38.27M0.00100News CoverageShort Interest ↑SMLRSemler Scientific3.5109 of 5 stars$23.93+1.2%$74.25+210.3%-12.6%$361.17M$56.29M9.82120Trending NewsAnalyst ForecastNPCENeuroPace2.7596 of 5 stars$10.83+0.8%$16.60+53.3%+65.0%$357.76M$79.91M-12.88170Analyst ForecastDRTSAlpha Tau Medical2.6311 of 5 stars$4.16+3.9%$9.00+116.6%+92.3%$357.52MN/A-8.7880News CoveragePositive NewsAnalyst ForecastRXSTRxSight2.1559 of 5 stars$8.60+0.8%$10.00+16.3%-82.9%$351.47M$147.06M-10.74220Analyst ForecastTCMDTactile Systems Technology3.8583 of 5 stars$14.58-0.2%$16.83+15.5%+6.3%$325.10M$292.98M23.521,037Positive NewsAnalyst ForecastBWAYBrainsway2.9461 of 5 stars$16.05+1.1%$18.00+12.1%+74.4%$304.95M$41.02M61.73120News CoveragePositive News Related Companies and Tools Related Companies KIDS Competitors TMCI Competitors DCTH Competitors CARL Competitors SMLR Competitors NPCE Competitors DRTS Competitors RXST Competitors TCMD Competitors BWAY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APYX) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
